Global Fund Results Report 2022 details how the partnership played a critical role in supporting countries and communities to respond to the pandemic and continue the progress in the fight against HIV, TB and malaria.

The coverage of treatment and prevention interventions for HIV, TB and malaria in countries where the Global Fund invests has increased rapidly since we were created in 2002. However, while the growth in HIV coverage levels remains steady, TB and malaria coverage have both declined in recent years. 

As long as stigma and discrimination are present in the society, both the global and
local initiatives will continue to fail to meet the objectives of reducing new infections,
increasing voluntary counselling and testing, having better linkages to care, and
increasing the number of PLHIV whose viral load is suppressed.

Pioneered in Sweden, where it became law in 1999, this model has now been adopted by six European countries (Norway 2009, Iceland 2009, Northern Ireland 2015, France 2016, Republic of Ireland 2017) and two other countries further afield (Canada 2014, Israel 2017).